Nivolumab,Ipilimumab
BMS
['paradigm']
 potentially paradigm changing. does this mean we should consider adjuvant immunotherapy in place of chemotherapy for resected msi high stage 3 disease? albeit ongoing trials which will not report for years.
GI medical oncologist in New York City. Avid follower of visual, musical, and theatre arts.